Home Blog

Selective fluorination of Fc glycans enhances antibody-mediated effector functions – Research


Antibody effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and various complement-dependent activities are critically influenced by the structure and composition of Fc N-glycans. Terminal galactosylation is generally associated with enhanced FcγRIIIA binding and C1q recruitment, thereby improving antibody activities. Recent structural studies suggest that terminal galactose can restrict glycan flexibility and stabilize Fc conformation by interacting with CH2 domain residues, thereby reducing the entropic penalty for FcγRIIIA binding. Motivated by this structural insight, we hypothesized that fine-tuning galactose-mediated Fc glycan-Fc domain interactions via site-selective fluorination could further modulate Fc-receptor and Fc-complement interactions. To test this, we developed a chemoenzymatic glycoengineering approach to generate homogeneous antibodies bearing precisely fluorinated Fc N-glycans. Key to this strategy was the chemical synthesis of position-specific fluorinated full-length Fc glycans, which were subsequently installed onto the antibody via enzymatic Fc glycan remodeling catalyzed by a glycosynthase mutant. Using this platform, we constructed a panel of homogeneous fluorinated antibodies and evaluated their functional consequences. ELISA-based binding assays revealed that fluorination at the C2 or C6 position of terminal galactose significantly increased FcγRIIIA affinity. Corresponding enhancements in ADCC were confirmed using a cell-based reporter bioassay. Furthermore, fluorination at these positions also promoted C1q binding and elevated the antibody-dependent cellular phagocytosis potency in whole blood assays. These results collectively demonstrate that selective Fc glycan fluorination represents a unique strategy to enhance antibody effector functions, providing a paradigm for precision glycoengineering in antibody therapeutics.


Keywords:

ADCC; CDCP; Fc glycosylation; antibody glyco-engineering; fluorinated glycans.



Read more about this post…

Credits: Source

Disclaimer

Selective fluorination of Fc glycans enhances antibody-mediated effector functions – Research


Antibody effector functions such as antibody-dependent cellular cytotoxicity (ADCC) and various complement-dependent activities are critically influenced by the structure and composition of Fc N-glycans. Terminal galactosylation is generally associated with enhanced FcγRIIIA binding and C1q recruitment, thereby improving antibody activities. Recent structural studies suggest that terminal galactose can restrict glycan flexibility and stabilize Fc conformation by interacting with CH2 domain residues, thereby reducing the entropic penalty for FcγRIIIA binding. Motivated by this structural insight, we hypothesized that fine-tuning galactose-mediated Fc glycan-Fc domain interactions via site-selective fluorination could further modulate Fc-receptor and Fc-complement interactions. To test this, we developed a chemoenzymatic glycoengineering approach to generate homogeneous antibodies bearing precisely fluorinated Fc N-glycans. Key to this strategy was the chemical synthesis of position-specific fluorinated full-length Fc glycans, which were subsequently installed onto the antibody via enzymatic Fc glycan remodeling catalyzed by a glycosynthase mutant. Using this platform, we constructed a panel of homogeneous fluorinated antibodies and evaluated their functional consequences. ELISA-based binding assays revealed that fluorination at the C2 or C6 position of terminal galactose significantly increased FcγRIIIA affinity. Corresponding enhancements in ADCC were confirmed using a cell-based reporter bioassay. Furthermore, fluorination at these positions also promoted C1q binding and elevated the antibody-dependent cellular phagocytosis potency in whole blood assays. These results collectively demonstrate that selective Fc glycan fluorination represents a unique strategy to enhance antibody effector functions, providing a paradigm for precision glycoengineering in antibody therapeutics.


Keywords:

ADCC; CDCP; Fc glycosylation; antibody glyco-engineering; fluorinated glycans.



Read more about this post…

Credits: Source

Disclaimer

Cofilin-1 is a redox-sensitive guard of the NLRP3 inflammasome – Immunology Research

0


  • Fu, J., Schroder, K. & Wu, H. Mechanistic insights from inflammasome structures. Nat. Rev. Immunol. 24, 518–535 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome. Nat. Genet. 29, 301–305 (2001).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Aksentijevich, I. et al. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46, 3340–3348 (2002).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237–241 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357–1361 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vandanmagsar, B. et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17, 179–188 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Halle, A. et al. The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat. Immunol. 9, 857–865 (2008).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Heneka, M. T. et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature 493, 674–678 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Mauro, A. G. et al. The role of NLRP3 inflammasome in pericarditis: potential for therapeutic approahces. JACC Basic Transl. Sci. 6, 137–150 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Vecchie, A. et al. Interleukin-1 and the NLRP3 inflammasome in pericardial disease. Curr. Cardiol. Rep. 23, 157 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Andreeva, L. et al. NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation. Cell 184, 6299–6312 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • He, Y., Zeng, M. Y., Yang, D., Motro, B. & Nunez, G. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux. Nature 530, 354–357 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Shi, H. et al. NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component. Nat. Immunol. 17, 250–258 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schmacke, N. A. et al. IKKβ primes inflammasome formation by recruiting NLRP3 to the trans-Golgi network. Immunity 55, 2271–2284 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Petrilli, V. et al. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 14, 1583–1589 (2007).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225 (2011).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Bruchard, M. et al. Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the NLRP3 inflammasome and promotes tumor growth. Nat. Med. 19, 57–64 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tassi, S. et al. Altered redox state of monocytes from cryopyrin-associated periodic syndromes causes accelerated IL-1β secretion. Proc. Natl Acad. Sci. USA 107, 9789–9794 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Balow, J. E. Jr. et al. Microarray-based gene expression profiling in patients with cryopyrin-associated periodic syndromes defines a disease-related signature and IL-1-responsive transcripts. Ann. Rheum. Dis. 72, 1064–1070 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Park, Y. H., Wood, G., Kastner, D. L. & Chae, J. J. Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS. Nat. Immunol. 17, 914–921 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Burger, D., Fickentscher, C., de Moerloose, P. & Brandt, K. J. F-actin dampens NLRP3 inflammasome activity via Flightless-I and LRRFIP2. Sci. Rep. 6, 29834 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lee, G. S. et al. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature 492, 123–127 (2012).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Gross, C. J. et al. K+ efflux-independent NLRP3 inflammasome activation by small molecules targeting mitochondria. Immunity 45, 761–773 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Finkel, T. Signal transduction by reactive oxygen species. J. Cell Biol. 194, 7–15 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Klemke, M. et al. Oxidation of cofilin mediates T cell hyporesponsiveness under oxidative stress conditions. Immunity 29, 404–413 (2008).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Klejnot, M. et al. Analysis of the human cofilin 1 structure reveals conformational changes required for actin binding. Acta Crystallogr. D Biol. Crystallogr. 69, 1780–1788 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cameron, J. M. et al. Polarized cell motility induces hydrogen peroxide to inhibit cofilin via cysteine oxidation. Curr. Biol. 25, 1520–1525 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat. Med. 21, 248–255 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hochheiser, I. V. et al. Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3. Nature 604, 184–189 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Munoz-Planillo, R. et al. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38, 1142–1153 (2013).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pfannstiel, J. et al. Human cofilin forms oligomers exhibiting actin bundling activity. J. Biol. Chem. 276, 49476–49484 (2001).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Leaver-Fay, A. et al. ROSETTA3: an object-oriented software suite for the simulation and design of macromolecules. Methods Enzymol. 487, 545–574 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Goddard, T. D. et al. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 27, 14–25 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Honorato, R. V. et al. The HADDOCK2.4 web server for integrative modeling of biomolecular complexes. Nat. Protoc. 19, 3219–3241 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xiao, L., Magupalli, V. G. & Wu, H. Cryo-EM structures of the active NLRP3 inflammasome disc. Nature 613, 595–600 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Sharif, H. et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature 570, 338–343 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. Science 381, eadg7492 (2023).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schubach, M., Maass, T., Nazaretyan, L., Roner, S. & Kircher, M. CADD v1.7: using protein language models, regulatory CNNs and other nucleotide-level scores to improve genome-wide variant predictions. Nucleic Acids Res. 52, D1143–D1154 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ioannidis, N. M. et al. REVEL: an ensemble method for predicting the pathogenicity of rare missense variants. Am. J. Hum. Genet. 99, 877–885 (2016).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Duncan, J. A. et al. Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl Acad. Sci. USA 104, 8041–8046 (2007).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Brinkschulte, R. et al. ATP-binding and hydrolysis of human NLRP3. Commun. Biol. 5, 1176 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Liston, A. & Masters, S. L. Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nat. Rev. Immunol. 17, 208–214 (2017).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Feng, S. et al. Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants. Nat. Immunol. 26, 511–523 (2025).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Cosson, C. et al. Functional diversity of NLRP3 gain-of-function mutants associated with CAPS autoinflammation. J. Exp. Med. 221, e20231200 (2024).

  • Yu, X. et al. Structural basis for the oligomerization-facilitated NLRP3 activation. Nat. Commun. 15, 1164 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Jones, J. D. & Dangl, J. L. The plant immune system. Nature 444, 323–329 (2006).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhou, R., Tardivel, A., Thorens, B., Choi, I. & Tschopp, J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat. Immunol. 11, 136–140 (2010).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Koenen, T. B. et al. Hyperglycemia activates caspase-1 and TXNIP-mediated IL-1β transcription in human adipose tissue. Diabetes 60, 517–524 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Masters, S. L. et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat. Immunol. 11, 897–904 (2010).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Klamt, F. et al. Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin. Nat. Cell Biol. 11, 1241–1246 (2009).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hoffmann, L. et al. Cofilin1 oxidation links oxidative distress to mitochondrial demise and neuronal cell death. Cell Death Dis. 12, 953 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Paunovska, K., Loughrey, D. & Dahlman, J. E. Drug delivery systems for RNA therapeutics. Nat. Rev. Genet. 23, 265–280 (2022).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Taya, T., Kami, D., Teruyama, F., Matoba, S. & Gojo, S. Peptide-encoding gene transfer to modulate intracellular protein–protein interactions. Mol. Ther. Methods Clin. Dev. 32, 101226 (2024).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Li, H. et al. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. Eur. J. Pharmacol. 928, 175091 (2022).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Tang, F. et al. First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers. Clin. Transl. Sci. 16, 1653–1666 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chae, J. J. et al. Gain-of function pyrin mutations induces NLRP3 protein-independent interleukin-1 activation and severe autoinflammation in mice. Immunity 34, 755–768 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • The PyMOL Molecular Graphics System, Version 3.0 (Schrödinger, 2023).

  • Pires, D. E., Ascher, D. B. & Blundell, T. L. mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics 30, 335–342 (2014).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pires, D. E., Ascher, D. B. & Blundell, T. L. DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Res. 42, W314–W319 (2014).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rodrigues, C. H., Pires, D. E. & Ascher, D. B. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 46, W350–W355 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rodrigues, C. H. M., Pires, D. E. V. & Ascher, D. B. DynaMut2: assessing changes in stability and flexibility upon single and multiple point missense mutations. Protein Sci. 30, 60–69 (2021).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Zhou, Y., Pan, Q., Pires, D. E. V., Rodrigues, C. H. M. & Ascher, D. B. DDMut: predicting effects of mutations on protein stability using deep learning. Nucleic Acids Res. 51, W122–W128 (2023).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Worth, C. L., Preissner, R. & Blundell, T. L. SDM—a server for predicting effects of mutations on protein stability and malfunction. Nucleic Acids Res. 39, W215–W222 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Frappier, V., Chartier, M. & Najmanovich, R. J. ENCoM server: exploring protein conformational space and the effect of mutations on protein function and stability. Nucleic Acids Res. 43, W395–W400 (2015).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhou, Y., Myung, Y., Rodrigues, C. H. M. & Ascher, D. B. DDMut-PPI: predicting effects of mutations on protein-protein interactions using graph-based deep learning. Nucleic Acids Res. 52, W207–W214 (2024).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rodrigues, C. H. M., Myung, Y., Pires, D. E. V. & Ascher, D. B. mCSM-PPI2: predicting the effects of mutations on protein–protein interactions. Nucleic Acids Res. 47, W338–W344 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Chen, S. et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature 625, 92–100 (2024).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Xue, L. C., Rodrigues, J. P., Kastritis, P. L., Bonvin, A. M. & Vangone, A. PRODIGY: a web server for predicting the binding affinity of protein–protein complexes. Bioinformatics 32, 3676–3678 (2016).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Kim, D. E., Chivian, D. & Baker, D. Protein structure prediction and analysis using the Robetta server. Nucleic Acids Res. 32, W526–W531 (2004).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     



  • Read more about this post…

    Credits: Source

    Disclaimer

    Scientists Just Built Atom-Sized Gates That Act Like Living Cells – Science News



    In-Pore Precipitation Reaction in a Solid-State NanoporeScientists have built atom-sized pores that act like living ion channels, opening the door to next-generation nanotech. Ion channels are extremely narrow pathways that are essential for many processes in living systems. To understand how ions move through these confined spaces, scientists need to build artificial pores at incredibly small scales. The tightest parts of […]



    Read more about this post…

    Credits: Source

    Disclaimer

    Subsequent SARS-CoV-2 Infection in Healthcare Workers: A Retrospective Cohort Study in Iran – Research



    Background:

    The evolution of SARS-CoV-2 has increased global COVID-19 case prevalence. Healthcare workers (HCWs) are particularly susceptible to reinfection due to their exposure to infected patients. This study aimed to explore the risk factors for subsequent SARS-CoV-2 infection among HCWs.


    Methods:

    This retrospective study was conducted in a teaching hospital affiliated with the Iran University of Medical Sciences between March 2021 and October 2021. HCWs completed an online survey to gather information about their COVID-19 infection history. Subsequent SARS-CoV-2 infection was defined as two or more infections, regardless of the time frame interval. Individuals who experienced a second infection within 90 days of the initial infection were considered to have a recurrence, and others were considered to have a reinfection. The generalized estimation equation was utilized to develop a multivariable prediction model.


    Results:

    A total of 601 HCWs (60.2% female), mostly aged 18-29 years (47.4%), participated in this study. We observed 90 episodes of subsequent SARS-CoV-2 infection among HCWs, including 72 individuals (11.98%). Among them, 9 participants (1.5%) experienced recurrence, while 43 participants (7.1%) reported reinfection. In the multivariable analysis, vaccination significantly reduced the risk of subsequent SARS-CoV-2 infection, whereas nurses and those working in COVID-19 wards faced twice the risk.


    Conclusion:

    The frequency of subsequent SARS-CoV-2 infection is significant among HCWs. Vaccination status, occupation type, and workplace are key factors influencing the risk of future infections.


    Keywords:

    COVID‐19; SARS‐CoV‐2; healthcare workers; occupational risk; pandemic; public health; reinfection; risk factors; vaccination.



    Read more about this post…

    Credits: Source

    Disclaimer

    Resurrected 3.2-Billion-Year-Old Enzyme Could Unlock the Origins of Life – Science News



    Abstract Origin of Life CellsBy reconstructing ancient nitrogen-processing enzymes, scientists are uncovering new clues about how early life survived on a very different Earth. Nitrogen is essential for life on Earth, yet most organisms cannot use it directly from the atmosphere. Scientists now believe this element may also provide important clues about how life first developed on our planet […]



    Read more about this post…

    Credits: Source

    Disclaimer

    Hyperoside Attenuates Lupus Nephritis-Associated Mesangial Cell Apoptosis via the P53/XAF1 Pathway: Integrative Bioinformatics and In Vitro Validation – Research



    Objective:

    This study aimed to explore potential molecular targets and pathways of Hyp in LN using integrative bioinformatics and network pharmacology, and to provide in vitro validation of key mechanistic hypotheses in an IFN-α-induced mesangial-cell injury model.


    Methods:

    Differential expression analysis was performed on multiple datasets to identify LN-related target genes. Integrative approaches including machine learning algorithms, network pharmacology, and molecular docking were employed to explore the binding interactions between Hyp and target proteins. In vitro experiments were conducted to validate the mechanism by which Hyp intervenes in glomerular mesangial cell apoptosis.


    Results:

    A total of 18 genes were identified as potential targets involved in Hyp-induced modulation of LN progression. Machine learning SHAP analysis identified 5 core genes (STAT1, RSAD2, OAS3, GBP1, XAF1) as key regulators. Molecular docking simulations revealed specific binding between Hyp and each target protein, with particularly strong binding affinity between Hyp and XAF1. Cellular experimental results demonstrated that Hyp could inhibit the P53/XAF1 signaling pathway, downregulate the expression of apoptosis-related proteins, and thereby alleviate glomerular mesangial cell apoptosis.


    Conclusion:

    Hyp attenuated IFN-α-induced glomerular mesangial cell apoptosis by suppressing the P53/XAF1 signaling pathway, suggesting a potential therapeutic mechanism in LN. These integrative bioinformatics and in vitro findings provide a rationale for future in vivo validation and clinical translation.


    Keywords:

    P53/XAF1; apoptosis; glomerular mesangial cells; hyperoside; lupus nephritis.



    Read more about this post…

    Credits: Source

    Disclaimer

    Scientists Uncover Aging Link That Could Change How Cancer Is Treated – Science News



    Lung Cancer Tumor DiseaseA new study reveals how aging changes the biological behavior of lung cancer. Scientists at the University of Gothenburg have identified a protein that may increase the risk of lung cancer spreading and returning after treatment. Their findings suggest a possible path toward more targeted therapies, especially for older patients. Lung cancer is most common […]



    Read more about this post…

    Credits: Source

    Disclaimer

    Thermodynamic prediction of RNA cellular activity from sequence via conformational ensembles – Research



    The RNA sequence of HIV-1 TAR was systematically altered to change its propensity to adopt a functional secondary structure in the ensemble, measured using 1H CEST NMR. These minor sequence changes shifted the active-state propensity by ∼500-fold, quantitatively predicting changes in protein binding and cellular transactivation. These propensities could be inferred from secondary-structure prediction algorithms and incorporated into a thermodynamic framework to quantitatively predict how sequence changes alter protein-binding affinity and RNA cellular activity.



    Read more about this post…

    Credits: Source

    Disclaimer